The startup law in medical devices
Most device founders hire their co-founder + 2–3 engineers first. Wrong move in India. You need regulatory clarity before code. CDSCO approval timelines vary 18–36 months by device class. Hiring an engineer before knowing your classification wastes 8 months of salary and equity.
Your first hire should be a regulatory specialist with 5+ years CDSCO or MedTech regulatory experience. This person costs ₹18–24L annually but cuts your approval pathway from guessing to data. They map you to IVD vs device vs notified body vs direct CDSCO. This is non-negotiable in India.
Equity: get the bands right
Founding engineers (hires 1–2) get 0.5–1.2% equity. These are not co-founders. They have 2–3 year vesting. First regulatory expert gets 0.3–0.6% with 3-year vest. This seems backwards. It's not. Regulatory people in India have outside offers ($100k+ consulting gigs). You're asking them to bet on your runway, not your vision.
First clinical advisor (tie-in to hospital chains or ICMR networks) gets 0.2–0.3% + monthly retainer (₹40–60k). They work part-time, validate design in real settings. Manufacturing hire (plant manager or process engineer from Lupin, Cipla medical device arms) gets 0.25–0.4%. They prevent 12-month delays in scaling.
Sales/distribution hire gets 0.2–0.3% + performance bonus (1–2% of ARR). In India, this person owns hospital relationships, state tenders, e-marketplace listings. They're not glamorous but they determine if you hit ₹1.5Cr ARR by year 3.
Invert these bands and you'll hire five engineers before anyone checks if your device actually works in a government hospital.
What early hiring mistakes actually cost
Scenario: You hire a Stanford-dropout engineer as first employee (1% equity). Six months later, you realize you need Manatech and ICMR approvals before human trials. Your engineer can't help. You hire a regulatory person (gets 0.4%, dilutes engineer). Engineer leaves. You've burned ₹30L and lost 9 months. Real example: three device startups I've seen took this path in 2021–2022.
Another trap: hiring a healthcare MBA from IIM because they "understand the market." They don't understand tier-2 hospitals, government procurement, or why district hospitals use 15-year-old ultrasound machines. You need someone who's sold to 50+ hospitals, not someone with a case study. That MBA will cost you 4–6 months of repositioning.
Culture mistakes that stick
If your first five are all engineers, your culture becomes "build first, ask permission later." This destroys medical device startups in India. You'll ship features that can't be claimed, test protocols that violate notified body standards, and burn regulatory goodwill.
If your first hires include people who've worked in regulated industries (pharma, implants, in-vitro diagnostics), they carry the right paranoia. They'll ask "Can we claim this?" before design reviews. This saves 6–8 months later.
One more: hiring people from Bengaluru startups who've never touched compliance. They'll build processes for speed. You'll build for audits. Conflict starts month 3. By month 8, your first engineer has left and you've had zero progress on CDSCO strategy.
How India Stack timing matters here
The India Stack (DigiLocker, e-sign, UPI, Aadhaar) is reshaping medical device adoption. State health systems now log device usage digitally. ICMR's partnership framework rewards startups building digital-native devices. Your first hire should understand this. If your device doesn't integrate with state hospital systems (via Arogyasetu, similar platforms), you've built for yesterday.
Hire someone from a hospital IT background. Someone who's managed device workflows in 20+ public hospitals. They'll design for digital-first day one.
The sharp implication
If you're raising a seed round for a medical device startup in India, investors now ask: "Who's hire #1?" The answer should be a name, regulatory credentials, and proof they've navigated CDSCO before. If your answer is an engineer or a business hire, the investor knows you're 18 months away from the realization that you've been building the wrong thing. Get regulatory clarity before you get VC checks.